{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:40:56Z","timestamp":1791196856313,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1476-511x-12-158","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T02:01:20Z","timestamp":1383012080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis"],"prefix":"10.1186","volume":"12","author":[{"given":"Fady","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen K","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor M","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"1213_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","volume":"49","author":"G Deray","year":"2002","unstructured":"Deray G: Amphotericin B, nephrotoxicity. J Antimicrob Chemother. 2002, 49: 37-41. 10.1093\/jac\/49.suppl_1.37","journal-title":"J Antimicrob Chemother"},{"key":"1213_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1086\/507530","volume":"43","author":"LD Saravolatz","year":"2006","unstructured":"Saravolatz LD, Bern C, Adler-Moore J: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis. Clin Infect Dis. 2006, 43: 917-924. 10.1086\/507530","journal-title":"Clin Infect Dis"},{"key":"1213_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/infdis\/jir735","volume":"205","author":"VK Prajapati","year":"2012","unstructured":"Prajapati VK, Awasthi K, Yadav TP: An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis. J Infect Dis. 2012, 205: 333-336. 10.1093\/infdis\/jir735","journal-title":"J Infect Dis"},{"key":"1213_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jac\/dkr002","volume":"66","author":"VK Prajapati","year":"2011","unstructured":"Prajapati VK, Awasthi K, Gautam S: Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. J Antimicrob Chemother. 2011, 66: 874-879. 10.1093\/jac\/dkr002","journal-title":"J Antimicrob Chemother"},{"key":"1213_CR5","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1128\/AAC.46.8.2704-2707.2002","volume":"46","author":"G Delmas","year":"2002","unstructured":"Delmas G, Park S, Chen ZW: Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrob Agents Chemother. 2002, 46: 2704-2707. 10.1128\/AAC.46.8.2704-2707.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"1213_CR6","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/jps.10173","volume":"91","author":"I Segarra","year":"2002","unstructured":"Segarra I, Movshin DA, Zarif L: Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system. J Pharmaceut Sci. 2002, 91: 1827-1837. 10.1002\/jps.10173. 10.1002\/jps.10173","journal-title":"J Pharmaceut Sci"},{"key":"1213_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1128\/AAC.44.6.1463-1469.2000","volume":"44","author":"L Zarif","year":"2000","unstructured":"Zarif L, Graybill JR, Perlin D: Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob Agents Chemother. 2000, 44: 1463-1469. 10.1128\/AAC.44.6.1463-1469.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"1213_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijpharm.2012.06.062","volume":"436","author":"F Ibrahim","year":"2012","unstructured":"Ibrahim F, Gershkovich P, Sivak O: Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis. Int J Pharm. 2012, 436: 318-323. 10.1016\/j.ijpharm.2012.06.062","journal-title":"Int J Pharm"},{"key":"1213_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1476-511X-10-135","volume":"10","author":"O Sivak","year":"2011","unstructured":"Sivak O, Gershkovich P, Lin M: Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model. Lipids Health Dis. 2011, 10: 135- 10.1186\/1476-511X-10-135","journal-title":"Lipids Health Dis"},{"key":"1213_CR10","doi-asserted-by":"publisher","first-page":"e913","DOI":"10.1371\/journal.pntd.0000913","volume":"4","author":"EK Wasan","year":"2010","unstructured":"Wasan EK, Gershkovich P, Zhao J: A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model. PLoS Negl Trop Dis. 2010, 4: e913- 10.1371\/journal.pntd.0000913","journal-title":"PLoS Negl Trop Dis"},{"key":"1213_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jac\/dkp140","volume":"64","author":"P Gershkovich","year":"2009","unstructured":"Gershkovich P, Wasan EK, Lin M: Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. J Antimicrob Chemother. 2009, 64: 101-108. 10.1093\/jac\/dkp140","journal-title":"J Antimicrob Chemother"},{"key":"1213_CR12","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","volume":"44","author":"R Santangelo","year":"2000","unstructured":"Santangelo R, Paderu P, Delmas G: Efficacy of Oral Cochleate-Amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother. 2000, 44: 2356-2360. 10.1128\/AAC.44.9.2356-2360.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"1213_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.112.005660","volume":"65","author":"HD Williams","year":"2013","unstructured":"Williams HD, Trevaskis NL, Charman SA: Strategies to address low drug Solubility in Discovery and Development. Pharmacol Rev. 2013, 65: 315-499. 10.1124\/pr.112.005660","journal-title":"Pharmacol Rev"},{"key":"1213_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ejps.2012.02.008","volume":"46","author":"F Ibrahim","year":"2012","unstructured":"Ibrahim F, Gershkovich P, Sivak O: Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model. Eur J Pharm Sci: Official Journal of the European Federation for Pharmaceutical Sciences. 2012, 46: 323-328. 10.1016\/j.ejps.2012.02.008. 10.1016\/j.ejps.2012.02.008","journal-title":"Eur J Pharm Sci: Official Journal of the European Federation for Pharmaceutical Sciences"},{"key":"1213_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1084\/jem.35.2.127","volume":"35","author":"PD McMaster","year":"1922","unstructured":"McMaster PD: Do species lacking a gall Bladder possess its functional equivalent?. J Exp Med. 1922, 35: 127-140. 10.1084\/jem.35.2.127","journal-title":"J Exp Med"},{"key":"1213_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijpharm.2009.01.003","volume":"372","author":"EK Wasan","year":"2009","unstructured":"Wasan EK, Bartlett K, Gershkovich P: Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int J Pharm. 2009, 372: 76-84. 10.1016\/j.ijpharm.2009.01.003","journal-title":"Int J Pharm"},{"key":"1213_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0165-6147(96)01012-7","volume":"17","author":"S Hartsel","year":"1996","unstructured":"Hartsel S, Bolard J: Amphotericin B: new life for an old drug. Trends Pharmacol Sci. 1996, 17: 445-449. 10.1016\/S0165-6147(96)01012-7","journal-title":"Trends Pharmacol Sci"},{"key":"1213_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2011.11.023","volume":"416","author":"A Chattopadhyay","year":"2011","unstructured":"Chattopadhyay A, Jafurulla M: A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. Biochem Biophys Res Comm. 2011, 416: 7-12. 10.1016\/j.bbrc.2011.11.023","journal-title":"Biochem Biophys Res Comm"},{"key":"1213_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbrc.2010.07.099","volume":"399","author":"YD Paila","year":"2010","unstructured":"Paila YD, Saha B, Chattopadhyay A: Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Comm. 2010, 399: 429-433. 10.1016\/j.bbrc.2010.07.099","journal-title":"Biochem Biophys Res Comm"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-12-158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:45:27Z","timestamp":1630608327000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-12-158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-12-158","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,29]]},"assertion":[{"value":"26 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"158"}}